Actively Recruiting

Phase Not Applicable
Age: 5Years - 11Years
All Genders
NCT03075917

Validation of an Allergic Rhinitis Control Test in Children

Led by University Hospital, Montpellier · Updated on 2026-01-05

135

Participants Needed

6

Research Sites

530 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Allergic rhinitis is a common condition that affects adults as well as children and adolescents, often with impaired quality of life. Patients often report a poor level of satisfaction with the effectiveness of their treatment and are always looking for more drug combinations to improve their symptom. Several tools exist for assessing control of allergic rhinitis, but none has been validated in teenagers or in children. A study conducted in 2008, resulted in the validation of a self-administered control test of allergic rhinitis (ARCT) in patients from 12 years of age. We propose to adapt ARCT adult to pediatric population from 5 to 11 years old.

CONDITIONS

Official Title

Validation of an Allergic Rhinitis Control Test in Children

Who Can Participate

Age: 5Years - 11Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 5 to 11 years old, consulting a practitioner for an allergic rhinitis
  • Parents formulated their study participation agreement by signing the consent form.
Not Eligible

You will not qualify if you...

  • Patients that are already treated for the actual episode of allergic rhinitis and are satisfied of the treatment.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 6 locations

1

CH Louis Pasteur

Bagnols-sur-Cèze, France

Completed

2

Maison de santé de Lasalle

Lasalle, France, 30460

Terminated

3

CH de MILLAU

Millau, France

Completed

4

Centre (Ctre) Medical Ravas - Malbosc

Montpellier, France, 34080

Completed

5

University hospital of Montpellier

Montpellier, France, 34295

Actively Recruiting

6

Hôpital Trousseau,

Paris, France

Completed

Loading map...

Research Team

P

Pascal DEMOLY, Professor

CONTACT

A

Anca CHIRIAC, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

PREVENTION

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here